Literature DB >> 7849319

Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin.

A L Gurney1, W J Kuang, M H Xie, B E Malloy, D L Eaton, F J de Sauvage.   

Abstract

Thrombopoietin (TPO), the ligand for c-mpl, is a novel cytokine comprising an amino terminal domain with homology to erythropoietin and a glycosylated carboxyl terminal domain that does not bear overall homology to other known proteins. We report the cloning of cDNAs encoding the porcine and murine TPO and the characterization of the human TPO gene. The cDNA for an additional splice form (TPO-2) with a four-amino-acid deletion within the erythropoietin-like domain has been isolated and is conserved between humans, pigs, and mice. Species comparison of TPO shows that the amino terminal erythropoietin-like domain is highly conserved, while the carboxyl terminal domain is less conserved. Recombinant murine TPO and human TPO are each able to activate both the murine and human c-mpl receptors, indicating an absence of strict species specificity. Human TPO is encoded by a single gene consisting of six exons and located on chromosome 3q27-28.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7849319

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  PEGylation prevents the N-terminal degradation of megakaryocyte growth and development factor.

Authors:  P I Guerra; C Acklin; A A Kosky; J M Davis; M J Treuheit; D N Brems
Journal:  Pharm Res       Date:  1998-12       Impact factor: 4.200

2.  Splicing of constitutive upstream introns is essential for the recognition of intra-exonic suboptimal splice sites in the thrombopoietin gene.

Authors:  M Romano; R Marcucci; F E Baralle
Journal:  Nucleic Acids Res       Date:  2001-02-15       Impact factor: 16.971

Review 3.  The biology of thrombopoietin and thrombopoietin receptor agonists.

Authors:  David J Kuter
Journal:  Int J Hematol       Date:  2013-07-03       Impact factor: 2.490

4.  The last intron of the human thrombopoietin gene enhances expression in milk of transgenic mice.

Authors:  Yan Li; Mingqian Zhou; Hongwei Zhou; Yunshan Ning
Journal:  Funct Integr Genomics       Date:  2013-11-28       Impact factor: 3.410

5.  Limited therapeutic efficacy of thrombopoietin on the regeneration of steatotic livers.

Authors:  Kerstin Abshagen; Franziska Mertens; Christian Eipel; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia.

Authors:  Majed J Dasouki; Syed K Rafi; Adam J Olm-Shipman; Nathan R Wilson; Sunil Abhyankar; Brigitte Ganter; L Mike Furness; Jianwen Fang; Rodrigo T Calado; Irfan Saadi
Journal:  Blood       Date:  2013-10-01       Impact factor: 22.113

7.  Expression pattern of the thrombopoietin receptor (Mpl) in the murine central nervous system.

Authors:  Anna Ivanova; Jens Wuerfel; Juan Zhang; Olaf Hoffmann; Matthias Ballmaier; Christof Dame
Journal:  BMC Dev Biol       Date:  2010-07-28       Impact factor: 1.978

8.  A statistical method for predicting splice variants between two groups of samples using GeneChip expression array data.

Authors:  Wenhong Fan; Najma Khalid; Andrew R Hallahan; James M Olson; Lue Ping Zhao
Journal:  Theor Biol Med Model       Date:  2006-04-07       Impact factor: 2.432

9.  Complex splicing control of the human Thrombopoietin gene by intronic G runs.

Authors:  Roberto Marcucci; Francisco E Baralle; Maurizio Romano
Journal:  Nucleic Acids Res       Date:  2006-12-07       Impact factor: 16.971

10.  Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin.

Authors:  F J de Sauvage; K Carver-Moore; S M Luoh; A Ryan; M Dowd; D L Eaton; M W Moore
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.